Elizabeth J. Chang

Elizabeth J. Chang

Auto-generated profile, based on publicly available information

Elizabeth J. Chang

XenoTherapeutics Inc. Boston Massachusetts USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2023 in Xenotransplantation
Verified
Journal Article
Open access
PHPaul Holzer
Paul Holzer
ECElizabeth J. Chang
Elizabeth J. Chang
KRKaitlyn Rogers
Kaitlyn Rogers
JTJamie Tarlton
Jamie Tarlton
DLDiana Lu
Diana Lu
RMRod Monroy
Rod Monroy
Surgical intervention is required to successfully treat severe, large‐gap (≥4 cm) peripheral nerve injuries. However, all existing treatments have shortcomings and an alternative to the use of autologous nerves is needed. Human and porcine nerves are physiologically similar, with comparable dimensions and architecture, presence and distribution of Schwann cells, and conserved features of the extracellular matrix (ECM). We report the repair of fully transected radial nerves in 10 Rhesus Macaques using viable, whole sciatic nerve from genetically engineered (GalT‐KO), designated pathogen free (DPF) porcine donors. This resulted in the regeneration of the transected nerve, and importantly, recovery of wrist extension function, distal muscle reinnervation, and recovery of nerve conduction velocities and compound muscle action potentials similar to autologous controls. We also demonstrate the absence of immune rejection, systemic porcine cell migration, and detectable residual porcine material. Our preliminary findings support the safety and efficacy of viable porcine nerve transplants, suggest the interchangeable therapeutic use of cross‐species cells, and highlight the broader clinical potential of xenotransplantation.